Spotlight on S. boulardii, a probiotic lauded for its benefits in reducing gut inflammation, and for the treatment and prevention of diarrhoea-associated conditions including traveller’s diarrhoea.
Saccharomyces boulardii is a well-researched immunobiotic, which has been shown to restore intestinal integrity and potentially reduce pathogenic gut microbiota.
A recent meta-analysis published in June of 2015 has shown that saccharomyces boulardii is an effective intervention in the reduction of risk of antibiotic associated diarrhoea (AAD) in both children and adults.
Saccharomyces boulardii (SB) is a beneficial probiotic, non-colonising yeast. It modulates the host’s innate gastrointestinal (GIT) immune response and improves GIT integrity.
Belinda Reynolds explores the pathogenesis of D-Lactate and reveals it may not be the culprit first thought, but rather a victim of circumstance.